SpeeDx
PrivateLast Round
Series C
Feb 28, 2023
Total Funding Raised
$52.01M
Company Overview
SpeeDx is a molecular diagnostics company that develops innovative multiplex systems for clinical diagnostics utilizing real-time polymerase chain reaction technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SpeeDx Comparables
Compare SpeeDx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ChromaCode | 80% | |
| Seegene Inc. | 79% | |
| R-Biopharm AG | 78% | |
SpeeDx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Feb 28, 2023 | ||||
| Grant | Jul 16, 2021 | ||||
| Grant | May 10, 2021 | ||||
| Grant | Sep 3, 2020 | ||||
| Series B | Feb 11, 2020 | ||||
Series A | Aug 5, 2019 |
Key People
Founding team and executive leadership
SpeeDx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CARB-X | Grant |
| Platinum Asset Management | Series C |
| NSW Medical Device Fund | Grant |
| Northpond Ventures | Series C, Series A, Series B |
| Tattarang | Series C |
| Northpond Ventures | Series C, Series A, Series B |
| Australian Government Department of Industry, Science and Resources | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 5, 2019
$15M round led by Northpond Ventures.
- Sep 4, 2017
$2M raised from NSW Medical Device Fund.
SpeeDx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SpeeDx's valuation, stock price, and market status.